PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

First-of-its-kind test can predict dementia up to nine years before diagnosis

2024-06-06
(Press-News.org) Peer Reviewed | Observational study | People 

Researchers at Queen Mary University of London have developed a new method for predicting dementia with over 80% accuracy and up to nine years before a diagnosis. The new method provides a more accurate way to predict dementia than memory tests or measurements of brain shrinkage, two commonly used methods for diagnosing dementia. 

The team, led by Professor Charles Marshall, developed the predictive test by analysing functional MRI (fMRI) scans to detect changes in the brain’s ‘default mode network’ (DMN). The DMN connects regions of the brain to perform specific cognitive functions and is the first neural network to be affected by Alzheimer’s disease. 

The researchers used fMRI scans from over 1,100 volunteers from UK Biobank, a large-scale biomedical database and research resource containing genetic and health information from half a million UK participants, to estimate the effective connectivity between ten regions of the brain that constitute the default mode network. 

The researchers assigned each patient with a probability of dementia value based on the extent to which their effective connectivity pattern conforms to a pattern that indicates dementia or a control-like pattern.  

They compared these predictions to the medical data of each patient, on record with the UK Biobank. The findings showed that the model had accurately predicted onset of dementia up to nine years before an official diagnosis was made, and with greater than 80% accuracy. In the cases where the volunteers had gone on to develop dementia, it was also found that the model could predict within a two-year margin of error exactly how long it would take that diagnosis to be made. 

The researchers also examined whether changes to the DMN might be caused by known risk factors for dementia. Their analysis showed that genetic risk for Alzheimer's disease was strongly associated with connectivity changes in the DMN, supporting the idea that these changes are specific to Alzheimer's disease. They also found that social isolation was likely to increase risk of dementia through its effect on connectivity in the DMN. 

Charles Marshall, Professor and Honorary Consultant Neurologist, led the research team within the Centre for Preventive Neurology at Queen Mary’s Wolfson Institute of Population Health. He said: “Predicting who is going to get dementia in the future will be vital for developing treatments that can prevent the irreversible loss of brain cells that causes the symptoms of dementia. Although we are getting better at detecting the proteins in the brain that can cause Alzheimer’s disease, many people live for decades with these proteins in their brain without developing symptoms of dementia. We hope that the measure of brain function that we have developed will allow us to be much more precise about whether someone is actually going to develop dementia, and how soon, so that we can identify whether they might benefit from future treatments." 

Samuel Ereira, lead author and Academic Foundation Programme Doctor at the Centre for Preventive Neurology, Wolfson Institute of Population Health, said: “Using these analysis techniques with large datasets we can identify those at high dementia risk, and also learn which environmental risk factors pushed these people into a high-risk zone. Enormous potential exists to apply these methods to different brain networks and populations, to help us better understand the interplays between environment, neurobiology and illness, both in dementia and possibly other neurodegenerative diseases. fMRI is a non-invasive medical imaging tool, and it takes about 6 minutes to collect the necessary data on an MRI scanner, so it could be integrated into existing diagnostic pathways, particularly where MRI is already used.” 

Hojjat Azadbakht, CEO of AINOSTICS (an AI company collaborating with world-leading research teams to develop brain imaging approaches for the early diagnosis of neurological disorders) said: "The approach developed has the potential to fill an enormous clinical gap by providing a non-invasive biomarker for dementia. In the study published by the team at QMUL, they were able to identify individuals who would later develop Alzheimer’s disease up to 9 years before they received a clinical diagnosis. It is during this pre-symptomatic stage that emerging disease-modifying treatments are likely to offer the most benefit for patients." 

 

ENDS  

 

NOTES TO EDITORS    

  

Contact:    

Sophia Prout   

Faculty Communications Manager – Medicine and Dentistry    

Queen Mary University of London    

Email: s.prout@qmul.ac.uk  or press@qmul.ac.uk  

 

Paper details:    

Charles R. Marshall, Sam Ereira, Sheena Wates, Adeel Razi. “Early detection of dementia with default-mode network effective connectivity.” Published in Nature Mental Health.  

DOI: 10.1038/s44220-024-00259-5 

Available after publication at:  https://www.nature.com/articles/s44220-024-00259-5  

Under strict embargo until 10AM (BST) ON THURSDAY 6 JUNE 2024.  

A copy of the paper is available upon request.  

 

Funding information:  

UKB data access was funded by a grant from the Tom and Sheila Springer Charity. 

 

Conflicts of Interest Disclosures:  

None. 

 

About Queen Mary    

www.qmul.ac.uk  

At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.   

Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.     

Our reformer heritage informs our conviction that great ideas can and should come from anywhere. It’s an approach that has brought results across the globe, from the communities of east London to the favelas of Rio de Janeiro.     

We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.   

END


ELSE PRESS RELEASES FROM THIS DATE:

Popular chatbot is a politically left-leaning EU supporter

2024-06-06
With the European Parliament elections now underway, millions of EU citizens are finalizing their decisions about which political party best represents their views. But anyone using LlamaChat, one of the major new AI chatbots, is very likely to be confronted with biased answers. It turns out that the large language model developed by Meta, upon which LlamaChat is based, has clear political leanings. This has been demonstrated in a new study from the University of Copenhagen in which Department of Computer Science researchers examined the language model's knowledge of political groups in the European Parliament. Moreover, they tested LlamaChat’s ...

Doctors advise caution as energy drinks may trigger life-threatening cardiac arrhythmias in patients with genetic heart diseases

2024-06-06
Philadelphia, June 6, 2024 – A new study in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, examined the potential dangers of consuming energy drinks for patients with genetic heart diseases. A cohort of 144 sudden cardiac arrest survivors was examined at Mayo Clinic, of which seven patients (5%) had consumed one or more energy drinks in close proximity to their cardiac ...

Only around half of individuals disclose or believe they should reveal having an STI prior to sexual intercourse, research to-date suggests

2024-06-06
A review of research to-date reveals the complex nature of revealing a diagnosis of a sexually transmitted infection (STI) to a partner ahead of engaging in sexual activity. With individuals experiencing a variety of feelings and emotions related to the prospect of disclosure, the research shows that only around half or fewer individuals felt able to disclose their diagnosis to a partner before sexual engagement. Peer-reviewed results, published today in The Journal of Sex Research, also show a similar number of people believed they should have to disclose having a STI to a partner prior to engaging in sexual intercourse. In order ...

Climate crisis puts Australia’s ski industry on slippery slope, but not all hope is lost

Climate crisis puts Australia’s ski industry on slippery slope, but not all hope is lost
2024-06-06
Australia’s ski industry is at risk of major disruptions and shorter seasons if the current level of climate pollution continues, according to new modelling from Protect Our Winters Australia (POW) and The Australian National University (ANU).  The report found the average ski season across all resorts in Australia will be 44 days shorter by 2050 under a mid-greenhouse gas emissions scenario and 55 days shorter under a high-emissions scenario.   It also shows that despite a dramatic decline in snowfall under mid- and high-emissions scenarios, the ...

Tiny roundworms carve out unique parasitic niche inside pseudoscorpion’s protective covering

Tiny roundworms carve out unique parasitic niche inside pseudoscorpion’s protective covering
2024-06-06
CORVALLIS, Ore. – The early worm gets the arachnid, fossil research by an Oregon State University scientist has shown. In a parasitic first, a Baltic amber specimen has revealed that millions of years ago tiny worms known as nematodes were living inside of and feeding on the outer protective layer of pseudoscorpions. “This is very strange,” said George Poinar Jr., who has a courtesy appointment in the OSU College of Science. “No other invertebrate-associated nematodes are known to have this detailed habit.” Findings were published in Historical Biology. Pseudoscorpions are a highly diverse lineage of arachnid, said Poinar, an international expert in ...

Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns

2024-06-06
Drugs like Ozempic, Wegovy and Mounjaro have been around for years, but they’ve recently been making headlines due to a rise in popularity as weight loss agents. They all belong to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), which mimic a hormone (GLP-1) in the body that helps control insulin and blood glucose levels and promotes feelings of satiety. These drugs are extremely effective for blood glucose control and weight management, which, combined with their relatively limited side effect profile, makes them ...

How a protein component of nuclear pore complexes regulates development of blood cells and may contribute to myeloid disorders

How a protein component of nuclear pore complexes regulates development of blood cells and may contribute to myeloid disorders
2024-06-06
Nuclear pore complexes (NPCs) are channels composed of multiple proteins that ferry molecules in and out of the nucleus, regulating many critical cellular functions, such as gene expression, chromatin organization and RNA processes that influence cell survival, proliferation, and differentiation. In recent years, new studies, including work by Maximiliano D’Angelo, Ph.D., associate professor in the Cancer Metabolism and Microenvironment Program at Sanford Burnham Prebys, have noted that NPCs in cancer cells are different, but how ...

Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases

Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases
2024-06-06
A drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according to a new study published in JAMA Dermatology. The drug, abrocitinib, was found to cause minimal side effects during a small 12-week study led by University of Maryland School of Medicine (UMSOM) researchers. It was beneficial for those with an itching disease called prurigo nodularis as well as for those with chronic pruritus of unknown origin, a condition that causes chronic unexplainable itching symptoms. “Very ...

The problem with prison abolition? Misunderstanding it

2024-06-06
“Approximately one in seventy working people in the United States are employed by either the police or departments of corrections.” In recent years, and in particular, in the aftermath of the Black Lives Matter protests of 2020, activists have focused renewed attention on the role of prisons in the United States. Thinkers like Angela Davis have articulated the ways in which the prison-industrial complex serves the interest of an oppressive state by reinforcing race and class hierarchies and extracting value from its incarcerated population. But despite this surge of interest ...

The Lancet Psychiatry: One in six people who stop antidepressants will experience discontinuation symptoms as a direct result, finds most comprehensive study to date

2024-06-06
Peer-reviewed / Systematic review & meta-analysis / People   Embargoed access to the paper and linked comment and contact details for authors are available in Notes to Editors at the end of the release.     The first meta-analysis on the incidence of antidepressant discontinuation symptoms includes data from over 20,000 patients gathered from 79 randomised controlled trials and observational studies.  Overall, approximately one in three patients reported a discontinuation ...

LAST 30 PRESS RELEASES:

Label distribution similarity-based noise correction for crowdsourcing

The Lancet: Without immediate action nearly 260 million people in the USA predicted to have overweight or obesity by 2050

Diabetes medication may be effective in helping people drink less alcohol

US over 40s could live extra 5 years if they were all as active as top 25% of population

Limit hospital emissions by using short AI prompts - study

UT Health San Antonio ranks at the top 5% globally among universities for clinical medicine research

Fayetteville police positive about partnership with social workers

Optical biosensor rapidly detects monkeypox virus

New drug targets for Alzheimer’s identified from cerebrospinal fluid

Neuro-oncology experts reveal how to use AI to improve brain cancer diagnosis, monitoring, treatment

Argonne to explore novel ways to fight cancer and transform vaccine discovery with over $21 million from ARPA-H

Firefighters exposed to chemicals linked with breast cancer

Addressing the rural mental health crisis via telehealth

Standardized autism screening during pediatric well visits identified more, younger children with high likelihood for autism diagnosis

Researchers shed light on skin tone bias in breast cancer imaging

Study finds humidity diminishes daytime cooling gains in urban green spaces

Tennessee RiverLine secures $500,000 Appalachian Regional Commission Grant for river experience planning and design standards

AI tool ‘sees’ cancer gene signatures in biopsy images

Answer ALS releases world's largest ALS patient-based iPSC and bio data repository

2024 Joseph A. Johnson Award Goes to Johns Hopkins University Assistant Professor Danielle Speller

Slow editing of protein blueprints leads to cell death

Industrial air pollution triggers ice formation in clouds, reducing cloud cover and boosting snowfall

Emerging alternatives to reduce animal testing show promise

Presenting Evo – a model for decoding and designing genetic sequences

Global plastic waste set to double by 2050, but new study offers blueprint for significant reductions

Industrial snow: Factories trigger local snowfall by freezing clouds

Backyard birds learn from their new neighbors when moving house

New study in Science finds that just four global policies could eliminate more than 90% of plastic waste and 30% of linked carbon emissions by 2050

Breakthrough in capturing 'hot' CO2 from industrial exhaust

New discovery enables gene therapy for muscular dystrophies, other disorders

[Press-News.org] First-of-its-kind test can predict dementia up to nine years before diagnosis